Wonbiogen Co., Ltd. (KOSDAQ:307280)

South Korea flag South Korea · Delayed Price · Currency is KRW
6,620.00
-340.00 (-4.89%)
At close: Apr 2, 2026
Market Cap47.74B +17.6%
Revenue (ttm)35.24B +15.8%
Net Income6.62B +16.3%
EPS933.00 +16.3%
Shares Out7.09M
PE Ratio7.21
Forward PEn/a
Dividend140.00 (2.11%)
Ex-Dividend DateDec 29, 2025
Volume32,854
Average Volume26,157
Open6,900.00
Previous Close6,960.00
Day's Range6,620.00 - 6,970.00
52-Week Range4,765.00 - 8,400.00
Beta0.68
RSI38.41
Earnings DateApr 3, 2026

About Wonbiogen

Wonbiogen Co., Ltd. manufactures and sells wound dressings in South Korea, rest of Asia, Europe, and internationally. It operates through Wound Dressing and Daily Necessities divisions. The company offers polyurethane foam and hydrocolloid dressings; cosmetics; other dressings; and daily necessities. It also provides medical, organic, and inorganic materials; and laundry detergents. Wonbiogen Co., Ltd. was founded in 2006 and is headquartered in Gumi-si, South Korea. [Read more]

Industry Orthopedic, Prosthetic, and Surgical Appliances and Supplies
Founded 2006
Employees 77
Stock Exchange KOSDAQ
Ticker Symbol 307280
Full Company Profile

Financial Performance

In 2025, Wonbiogen's revenue was 35.24 billion, an increase of 15.78% compared to the previous year's 30.44 billion. Earnings were 6.62 billion, an increase of 16.27%.

Financial Statements